Giovanni Smania, PhD

Senior Consultant & Team Leader
Pharmetheus AB, Italy

Poster(s):

• (S-075) Exposure-Overall Survival Analysis for Quizartinib in Newly Diagnosed Patients with FLT3-Internal-Tandem-Duplication-Positive Acute Myeloid Leukemia
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT